Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 136

1.

A definition and ethical evaluation of overdiagnosis.

Carter SM, Degeling C, Doust J, Barratt A.

J Med Ethics. 2016 Jul 8. pii: medethics-2015-102928. doi: 10.1136/medethics-2015-102928. [Epub ahead of print]

PMID:
27402883
2.

Doctors' experience of the contraceptive consultation: a qualitative study in Australia.

Kelly M, Inoue K, Black KI, Barratt A, Bateson D, Rutherford A, Stewart M, Richters J.

J Fam Plann Reprod Health Care. 2016 May 12. pii: jfprhc-2015-101356. doi: 10.1136/jfprhc-2015-101356. [Epub ahead of print]

PMID:
27172879
3.

Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography.

Jacklyn G, Glasziou P, Macaskill P, Barratt A.

Br J Cancer. 2016 May 24;114(11):1269-76. doi: 10.1038/bjc.2016.90. Epub 2016 Apr 28.

PMID:
27124337
4.

Australian women's attitudes towards and understandings of the subdermal contraceptive implant: a qualitative study of never-users.

Inoue K, Kelly M, Barratt A, Bateson D, Rutherford A, Black KI, Stewart M, Richters J.

J Fam Plann Reprod Health Care. 2016 Mar 3. pii: jfprhc-2014-101132. doi: 10.1136/jfprhc-2014-101132. [Epub ahead of print]

PMID:
26941357
5.

Walking the tightrope: communicating overdiagnosis in modern healthcare.

McCaffery KJ, Jansen J, Scherer LD, Thornton H, Hersch J, Carter SM, Barratt A, Sheridan S, Moynihan R, Waller J, Brodersen J, Pickles K, Edwards A.

BMJ. 2016 Feb 5;352:i348. doi: 10.1136/bmj.i348. No abstract available.

PMID:
26850726
6.

Application of Genetic Testing in Hypertrophic Cardiomyopathy for Preclinical Disease Detection.

Ingles J, Burns C, Barratt A, Semsarian C.

Circ Cardiovasc Genet. 2015 Dec;8(6):852-9. doi: 10.1161/CIRCGENETICS.115.001093. No abstract available.

PMID:
26671970
7.

The importance of enabling informed decision making for women considering breast cancer screening.

Hersch J, Barratt A, Jansen J, Irwig L, McGeechan K, Jacklyn G, Thornton H, Dhillon H, Houssami N, McCaffery K.

J Med Screen. 2016 Mar;23(1):55. doi: 10.1177/0969141315612818. Epub 2015 Nov 17. No abstract available.

PMID:
26582494
8.

Perspective: The risks of overdiagnosis.

Barratt A.

Nature. 2015 Nov 19;527(7578):S104. doi: 10.1038/527S104a. No abstract available.

PMID:
26580156
9.

How different terminology for ductal carcinoma in situ impacts women's concern and treatment preferences: a randomised comparison within a national community survey.

McCaffery K, Nickel B, Moynihan R, Hersch J, Teixeira-Pinto A, Irwig L, Barratt A.

BMJ Open. 2015 Nov 2;5(11):e008094. doi: 10.1136/bmjopen-2015-008094.

10.

How different terminology for ductal carcinoma in situ (DCIS) impacts women's concern and management preferences: A qualitative study.

Nickel B, Barratt A, Hersch J, Moynihan R, Irwig L, McCaffery K.

Breast. 2015 Oct;24(5):673-9. doi: 10.1016/j.breast.2015.08.004. Epub 2015 Sep 12.

PMID:
26376460
11.

Can consumers learn to ask three questions to improve shared decision making? A feasibility study of the ASK (AskShareKnow) Patient-Clinician Communication Model® intervention in a primary health-care setting.

Shepherd HL, Barratt A, Jones A, Bateson D, Carey K, Trevena LJ, McGeechan K, Del Mar CB, Butow PN, Epstein RM, Entwistle V, Weisberg E.

Health Expect. 2015 Sep 14. doi: 10.1111/hex.12409. [Epub ahead of print]

PMID:
26364752
12.

Reductions in immunosuppression after haematological or solid organ cancer diagnosis in kidney transplant recipients.

Hope CM, Krige AJ, Barratt A, Carroll RP.

Transpl Int. 2015 Nov;28(11):1332-5. doi: 10.1111/tri.12638. Epub 2015 Jul 29.

PMID:
26174703
13.

Screening for Cervical, Prostate, and Breast Cancer: Interpreting the Evidence.

Carter SM, Williams J, Parker L, Pickles K, Jacklyn G, Rychetnik L, Barratt A.

Am J Prev Med. 2015 Aug;49(2):274-85. doi: 10.1016/j.amepre.2015.01.009. Epub 2015 Jun 16. Review.

PMID:
26091929
14.

Public Opinions about Overdiagnosis: A National Community Survey.

Moynihan R, Nickel B, Hersch J, Beller E, Doust J, Compton S, Barratt A, Bero L, McCaffery K.

PLoS One. 2015 May 20;10(5):e0125165. doi: 10.1371/journal.pone.0125165. eCollection 2015.

15.

What do you think overdiagnosis means? A qualitative analysis of responses from a national community survey of Australians.

Moynihan R, Nickel B, Hersch J, Doust J, Barratt A, Beller E, McCaffery K.

BMJ Open. 2015 May 19;5(5):e007436. doi: 10.1136/bmjopen-2014-007436.

16.

The challenge of overdiagnosis begins with its definition.

Carter SM, Rogers W, Heath I, Degeling C, Doust J, Barratt A.

BMJ. 2015 Mar 4;350:h869. doi: 10.1136/bmj.h869. No abstract available.

PMID:
25740625
17.

Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality.

Barratt A.

BMJ. 2015 Mar 3;350:h867. doi: 10.1136/bmj.h867. No abstract available.

PMID:
25736426
18.

Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial.

Hersch J, Barratt A, Jansen J, Irwig L, McGeechan K, Jacklyn G, Thornton H, Dhillon H, Houssami N, McCaffery K.

Lancet. 2015 Apr 25;385(9978):1642-52. doi: 10.1016/S0140-6736(15)60123-4. Epub 2015 Feb 18. Erratum in: Lancet. 2015 Apr 25;385(9978):1622.

PMID:
25701273
19.

Does research into contraceptive method discontinuation address women's own reasons? A critical review.

Inoue K, Barratt A, Richters J.

J Fam Plann Reprod Health Care. 2015 Oct;41(4):292-9. doi: 10.1136/jfprhc-2014-100976. Epub 2015 Jan 20. Review.

PMID:
25605480
20.

A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening.

Barratt A, Irwig L, Glasziou P.

Int J Cancer. 2015 May 15;136(10):2486. doi: 10.1002/ijc.29270. Epub 2014 Nov 18. No abstract available.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk